This trial has completed enrollment.
Sign up for alerts for new studies that you may qualify for.
Systemic Lupus Erythematosus (SLE) Clinical Research
We know Systemic Lupus Erythematosus (SLE) can affect every area of your life. A new Systemic Lupus Erythematosus (SLE) Clinical Trial for adults living with Systemic Lupus Erythematosus (SLE). This nationwide study is evaluating a new investigational medication to reduce symptoms of Systemic Lupus Erythematosus (SLE).
Eligibility
To take part in the study, participants should:
- Be 18 to 75 years of age
- Have a diagnosis of active systemic lupus erythematosus (SLE)
- Have not been diagnosed with other autoimmune diseases (for example, multiple sclerosis, psoriasis, inflammatory bowel disease, etc.)
Study details
- Compensation for time and travel is available
No health insurance is required
- Study related drug and care from a dedicated medical staff will be provided at no cost
- The study will help to develop a potential treatment for Systemic Lupus Erythematosus (SLE)